Evidence map›Paper›PMID 36985112›Full record

ArticleMicromachines2023

A Multi-Label Detection Deep Learning Model with Attention-Guided Image Enhancement for Retinal Images.

Zhenwei Li, Mengying Xu, Xiaoli Yang, Yanqi Han, Jiawen Wang

Abstract read
In one paragraph

Article in Micromachines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Hybrid attention-based deep learning for multi-label ophthalmic disease detection on fundus images.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhenwei LiCollege of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471032, China.
Mengying XuCollege of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471032, China.
Xiaoli YangCollege of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471032, China.
Yanqi HanCollege of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471032, China.
Jiawen WangCollege of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471032, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At present, multi-disease fundus image classification tasks still have the problems of small data volumes, uneven distributions, and low classification accuracy. In order to solve the problem of large data demand of deep learning models, a multi-disease fundus image classification ensemble model based on gradient-weighted class activation mapping (Grad-CAM) is proposed. The model uses VGG19 and ResNet50 as the classification networks. Grad-CAM is a data augmentation module used to obtain a network convolutional layer output activation map. Both the augmented and the original data are used as the input of the model to achieve the classification goal. The data augmentation module can guide the model to learn the feature differences of lesions in the fundus and enhance the robustness of the classification model. Model fine tuning and transfer learning are used to improve the accuracy of multiple classifiers. The proposed method is based on the RFMiD (Retinal Fundus Multi-Disease Image Dataset) dataset, and an ablation experiment was performed. Compared with other methods, the accuracy, precision, and recall of this model are 97%, 92%, and 81%, respectively. The resulting activation graph shows the areas of interest for model classification, making it easier to understand the classification network.

Indexed as

class activation mappingdata augmentationmodel fine-tuningmulti-label classification

Identifiers

PMID36985112
PMCPMC10054796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.